Podcasts about nhs

In the first of our Rosebuds in the week of International Women's Day, Gyles meets Dame Mary Archer, the scientist and former Chairs of Addenbrooke's Hospitals Trust and the Science Museum Group, made a Dame for her service to the NHS. Gyles talks to Dame Mary about her childhood, nurtured by a father who was highly ambitious for his daughters, who gave her a lifelong love of music. They talk about her interest in science, which began at primary school, and she and Gyles discuss whether scientists think differently to other people. They talk about Mary's time at Oxford University, where she studied chemistry and met and married Jeffrey Archer - and Gyles asks Mary about their relationship, and what drew these two apparently very different characters to each other. Mary and Gyles talk about some of the challenges she and Jeffrey have faced as a couple and about Mary's career as a scientist, and in public life. This is a long and in-depth conversation which gives a different, scientific, perspective on life. It's fascinating. Our thanks to Dame Mary Archer. Don't forget to subscribe to our YouTube here. Join The Rosebud Family here. And visit our website here. Hosted on Acast. See acast.com/privacy for more information.

What is lifestyle economics and why does it matter? The IEA's Christopher Snowdon is a fun-loving political thinker and explains his opposition to puritanism, why we should have more freedom and what that would mean for our policies on smoking, alcohol, gambling and the very existence of the NHS. Also... what are ultra-processed foods and are they necessarily bad? THE POLITICAL PARTY LIVE9 March: Zack Polanski30 March: Lisa Nandy 20 April: Shabana Mahmoodhttps://nimaxtheatres.com/shows/the-political-party-with-matt-forde/SIGN UP to Matt's mailing list to get free audience tickets to his Radio 4 series:https://www.mattforde.com/mailing-list SEE Matt's brand new stand-up tour 'Defying Calamity' across the UK:https://www.mattforde.com/live-shows Hosted on Acast. See acast.com/privacy for more information.

Morse code transcription: vvv vvv Brit Awards 2026 The real winners and losers Flights cancelled as travel warnings issued after US Israeli strikes on Iran What we know so far about the US Israel attacks and Iran and x27 s retaliation Why are more GPs opting to work outside the NHS We found out wed bought fake flights at check in Ayatollah Ali Khamenei Irans defiant leaders grip on power ends One killed and 11 injured at Dubai and Abu Dhabi airports as Iran strikes region Trumps bet on Iranian regime change could be his biggest gamble yet Lyse Doucet This is an extraordinary moment Iran has been preparing for UK troops and civilians put at risk by indiscriminate Iran strikes, Healey says

A 40-year career retrospective of Dame Tracey Emin's work has opened at the Tate Modern in London, featuring many of the artist's most iconic pieces, from her controversial, Turner Prize shortlisted My Bed (1998) to her neon artworks, textiles, bronze sculptures, photos, and paintings. Called A Second Life, it explores the connections and tensions between her early career and the work she's created since 2020, when she was diagnosed with cancer and underwent a huge operation. Tracey joins Anita Rani to discuss her body of work.Student midwives have contacted us to say many of them are struggling to find jobs despite a serious shortage of midwives in the NHS. A new survey from the Royal College of Midwives finds 31% of newly qualified midwives are still not employed in the role, and the majority of those who have found employment are on fixed-term contracts. Nuala McGovern hears from Safia, who is in her final year of midwifery training, and Gill Walton, Chief Executive of the Royal College of Midwives.Molly vs the Machines is a new feature-length documentary that tells the story of Ian Russell and his fight for online safety after his daughter Molly took her own life in 2017 following months of viewing content relating to self-harm and suicide on social media. Molly's friends Charlotte Campbell and Sophie Conlan tell Anita why it was important for them to take part in the film.In collaboration with our Send in the Spotlight podcast, Nuala speaks to Schools Standards Minister Georgia Gould about the government's proposed SEND reforms.Writer and actor Kyla Harris joins Clare McDonnell to discuss reframing disability with her acclaimed BBC comedy We Might Regret This, which she co-created.Presenter: Anita Rani Producer: Dianne McGregor

EMDR in Practice: The Functional Model – When Do You Become a Qualified Counsellor? In Episode 367 of the Counselling Tutor Podcast, your hosts Rory Lees-Oakes and Ken Kelly explore three timely and important topics for counsellors, psychotherapists, and students. Firstly, in Ethical, Sustainable Practice, Rory and Ken explore talking to clients about AI in therapy, discussing the growing presence of artificial intelligence (AI) in clients' lives and why therapists need to address the risks, ethics, and boundaries of AI use within the therapeutic contract. Then, in Practice Matters, Rory is joined by Andrew Kidd for the second part of their conversation on EMDR, focusing on the functional model and how EMDR works in practice to help clients reprocess trauma. Finally, in Student Services, Rory and Ken unpack a common source of confusion for trainees: when you actually become “qualified” as a counsellor, and how this differs from accreditation and employability. Talking to Clients About AI in Therapy [starts at 03:08 mins] Rory and Ken explore talking to clients about AI in therapy, examining why counsellors need to understand and address clients' use of AI and how to ethically integrate this into therapeutic practice. Key points discussed include: Many clients are already using AI tools (such as large language models) for emotional support and guidance, often without understanding the risks. AI does not hold duty of care, ethical accountability, or safeguarding responsibilities, unlike a trained therapist. Responses from AI can sound confident and empathic but may be inaccurate, inappropriate, or harmful. Client data shared with AI tools may be stored, analysed, and used commercially, with no guarantee of confidentiality. Including AI use within the therapy contract helps protect clients and supports ethical, defensible practice. EMDR in Practice: The Functional Model [starts at 41:03 mins] In this second interview, Andrew Kidd explains how EMDR works in the therapy room and how it helps the brain reprocess traumatic memories. Key points from this conversation include: Trauma is understood not as what happened, but as what happens inside the nervous system as a result of events. EMDR works by activating the brain's natural healing mechanisms through bilateral stimulation (eye movements, taps, or tones). Bilateral stimulation helps clients stay grounded in the present while safely processing past memories. Clients do not need to recount traumatic events in full detail for EMDR to be effective. After reprocessing, memories often feel more distant and less emotionally charged, allowing clients to live more freely in the present. When Do You Become a Qualified Counsellor? [starts at 01:02:11 mins] Rory and Ken clarify the difference between being qualified, accredited, and employable within the counselling profession. Key points include: Completing a recognised counselling diploma (with supervised practice) means you are technically a qualified counsellor. Counselling is not a legally protected title in the UK and relies on voluntary regulation via professional bodies. Many employers (such as the NHS and EAPs) now require accreditation, which comes after significant post-qualification practice hours. Accreditation often involves additional competencies and assessments not covered in initial training. Understanding this career pathway early can help students plan realistically and stay resilient in their professional journey. Links and Resources Counselling Skills Academy Advanced Certificate in Counselling Supervision Basic Counselling Skills: A Student Guide Counsellor CPD Counselling Study Resource Counselling Theory in Practice: A Student Guide Counselling Tutor Training and CPD Facebook group Website Online and Telephone Counselling: A Practitioner's Guide Online and Telephone Counselling Course

Pioneering scheme transforms mental health care in Bradford. The NHS Trust is using projects including allotment visits, canal-side walks and VR headsets showing footage of the local moors, as part of its treatment for patients suffering from a range of mental health problems. Practionioner Cathy Schofield shares how this could become the future of NHS mental health care. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Sleep deprived parents everywhere are tempted to reach for anything that might help them get a little more sleep overnight – but can products promising to encourage babies to snooze for longer – really do that? And is there any science to back it up?That is exactly what tired Dad-of-three Dave wanted to know – and whether there were any future implications from using these gadgets, docks, blinds and sleep bags? New Dad Greg Foot speaks to Director of the Durham Infancy and Sleep Centre Professor Helen Ball, to find out. You can also read the official Safer Sleep guidance, by copy and pasting the links below into your browser:NHS - https://www.nhs.uk/best-start-in-life/baby/baby-basics/newborn-and-baby-sleeping-advice-for-parents/safe-sleep-advice-for-babies/Lullaby Trust - https://www.lullabytrust.org.uk/baby-safety/safer-sleep-information/safer-sleep-overview/RESEARCHER: PHIL SANSOMPRODUCER: KATE HOLDSWORTH & GREG FOOT

Should some children be given drugs to stop them going through puberty?That's the question the NHS, the government and an independent research and ethics committee have been trying to answer.The “Pathways” trial, backed by the NHS and led by a team from King's College London, aims to test the effectiveness and safety of puberty blockers for children experiencing gender dysphoria.At the end of 2025, the trial was approved to go ahead. Health Secretary Wes Streeting reassured parliamentary colleagues it “could not have received more oversight and scrutiny”. But now the agency in charge of medicine regulation has U-turned. The study is now paused because of ethical and safety concerns. All of which, Hannah Barnes reports today on the New Statesman website, they knew about when they first approved it.So how did the study get approved in the first place? And what does this tell us about the systems we trust to ensure medical research is safe and ethical?Also: Baroness Amos has released the interim findings from her review into England's maternity care, and says the system is "not working". Oli Dugmore is joined by Hannah Barnes to discuss.READ MOREInside the decision to pause the puberty blockers trialEngland's maternity system "not working" for anyone, report saysSAVE £££ THIS CHRISTMAS:⭐️ Gift big ideas, bold politics, and proper journalism from just £2LISTEN AD-FREE:

After a six-month-long investigation into maternity care in England, the government has published its initial findings. The report reveals a catalog of failures at 12 NHS trusts – from inadequate staffing and poor facilities to racial discrimination. So what do bereaved families make of the findings? And can this broken system be fixed?This podcast was brought to you thanks to the support of readers of The Times and The Sunday Times. Subscribe today: http://thetimes.com/thestoryGuests: Eleanor Hayward, health editor, The Times. Poppy Koronka, health reporter, The Times. Host: Luke Jones.Producer: Micaela Arneson. We want to hear from you - email: thestory@thetimes.comRead more: NHS ‘incentivised' to record baby deaths as stillbornFurther listening: Inside England's maternity scandal, part onePhoto: Getty Images.This podcast was brought to you thanks to subscribers of The Times and The Sunday Times. To enjoy unlimited digital access to all our journalism subscribe here. Hosted on Acast. See acast.com/privacy for more information.

Sleep deprived parents everywhere are tempted to reach for anything that might help them get a little more sleep overnight – but can products promising to encourage babies to snooze for longer – really do that? And is there any science to back it up?That is exactly what tired Dad-of-three Dave wanted to know – and whether there were any future implications from using these gadgets, docks, blinds and sleep bags? New Dad Greg Foot speaks to Director of the Durham Infancy and Sleep Centre Professor Helen Ball, to find out. You can also read the official Safer Sleep guidance, by copy and pasting the links below into your browser:NHS - https://www.nhs.uk/best-start-in-life/baby/baby-basics/newborn-and-baby-sleeping-advice-for-parents/safe-sleep-advice-for-babies/Lullaby Trust - https://www.lullabytrust.org.uk/baby-safety/safer-sleep-information/safer-sleep-overview/RESEARCHER: PHIL SANSOMPRODUCER: KATE HOLDSWORTH & GREG FOOT

In this episode we answer listener questions covering emergency funds for higher and additional rate taxpayers, and inheritance tax considerations around beneficiary SIPPs. We also discuss whether couples should rebalance pension contributions, the key steps to take before retiring abroad, and what to know about DB pension transfers. Finally, we look at cross-border pension taxation using the UK–Denmark double taxation treaty as an example. Shownotes: https://meaningfulmoney.tv/QA40    01:20  Question 1 Hi Pete & Roger, Thanks for all your helpful and easy to understand information. I have only been on my financial wellbeing journey for a year.  I work in the NHS and am in a higher tax bracket. I am fully enrolled in the NHS pension, more out of previous disinterest than any actual action on my part. I am single and currently saving up for a down payment on a house in about 4/5yrs. I maxed out my ISA last year and expect to do the same this year; this includes money for the down payment. I also took out a SIPP which I only recalled last year; I took it out 20+ years ago. However I am still waiting for a statement from the pension office before my accountant can work out how much more I can add to the SIPP.  In the interim I have my emergency fund in a premium bond (20k) but am worried it's being eroded by inflation. I expect to be an additional tax payer in the next few years. Where should I keep my excess cash? More in premium bonds with no tax but erosion by inflation; or open GIA or more in high interest savings account and pay the tax? Or is there another option you would recommend? Btw I have £600 in crypto (Coinbase and Etherium) but don't plan to put more than £400 more in then plan to forget about it. It's a tiny fraction of what I put in my ISA. Thanks, Joy   04:46  Question 2 Dear Pete and Roger. Love the podcast. I think it is essential listening for those wanting to elevate their knowledge of the incredibly important subject of financial planning and it also highlights the value add that financial professionals can provide. My mother is 79 and has a comfortable guaranteed inflation linked income via state and civil service pension, which is supplemented by savings (maxed premium bonds & healthy cash savings) and investments held in ISAs and a beneficiary SIPP from my late father who passed before 75yrs old (therefore the assets are income and CGT free). My mother is keen to minimise the IHT on the estate both her and my father worked so hard to create. Despite her comfortable situation, I still have to encourage her to spend and use your very helpful '40% off sticker' analogy on a regular basis. It is my understanding that SIPPs will be subject to IHT and income tax from 2027. As my sister and I are both additional rate taxpayers, we will potentially be subject to 67% tax on any assets remaining in the SIPP if the estate is above £1m IHT threshold. While the '67% off sticker' analogy is even more helpful to encourage her spending, it has triggered some planning. We are drawing down the beneficiary SIPP to fund ISA each year for my mum – keeping the income and CGT tax benefits for my mum while removing it from the double income and IHT tax on death. As part of the IHT planning we are now considering regular gifts from surplus income. When combined with her guaranteed income, the assets in the beneficiary SIPP are more than sufficient so sustain her lifestyle until her age would be well into three figures. Based on my reading, it appears any drawdown from SIPPs are considered 'income' for gifting purposes, regardless of if they come from capital or income. Therefore she could start to draw more 'income' from the SIPP and gift this surplus which could be considered IHT free. Are there any limits to how much or how quickly she could reasonably drawdown from a SIPP so that it would no longer be considered 'income' by HMRC for IHT purposes? i.e could she empty the SIPP over a 5 yr period, gift that as excess income, then reduce the gifts to reflect a different income and or expenditure? While all the drawdown from SIPPs is considered 'income' for IHT purposes, the treatment of withdrawals from ISAs or other investments are distinguished between whether they are actually capital or income. Therefore, we have the added complication of needing to balance the 'income' drawdown from the beneficiary SIPP to make sure she doesn't eat into 'capital' of the ISAs and savings which would then mean the gifts from regular surplus income would then be considered part of the estate again. Our circumstances mean my mum feels slightly trapped between keeping the SIPP (so it is considered income for gifts from regular income but gets IHT taxed at 67%), continuing to use the beneficiary SIPP to fund ISAs (reduce IHT liability but lose flexibility to gift it as income), maybe change the investment engine of the ISAs from a lower yielding balanced solution to something with a higher natural yield, or do something else altogether (lump sum gifts and hope to survive 3yrs for taper or 7yrs). Any thoughts or suggestion would be appreciated. While there are some relatively niche circumstances, I think it covers two more broadly applicable IHT planning considerations SIPPs v ISAs under the new rules and regular gifts from surplus income. Thanks in advance Stephen   17:06  Question 3 Hi Pete and Roger Thank you both for your continued help in navigating the financial maze and I am enjoying the listener questions. My wife works part time and is a basic rate tax payer. She pays into her workplace pension and contributes an additional 15%. Her pension provider receives 20% tax relief on these contributions. I am a higher rate tax payer and I make contributions to a SIPP. My pension provider receives 20% tax relief and I claim an additional 20% directly from HMRC. As a couple, we could stop making the additional contributions to my wife's pension and instead make them into my SIPP. This would give us an additional 40%, rather than 20%. Mathematically this makes sense. We haven't done this so far, as I like the idea that we are equally contributing to both of our pensions, for the future. It also helps keep things simple. I am mindful that one day, we may kick ourselves for not making this simple switch which may leave us with a significantly bigger pot, when we need it. What options would you consider in this decision of splitting pension contributions. Many thanks, Rob 20:17 Question 4 Dear Pete & Rog, I just wanted to say a heartfelt thank you for your podcast and the incredibly valuable information you share. Your conversations are not only insightful but also reassuring as I start to think more seriously about my own retirement planning! One of the things I'm considering is retiring abroad (somewhere sunny!) Spain most likely, and I wondered if you might explain the process you go through with such clients. Specifically, do you have a checklist, or a list of key questions, that you typically ask clients to work through before moving overseas? For example, I've learned that ISAs are not recognised in many EU countries (so it may be better to sell before leaving), and I imagine there are similar considerations around SIPPs/UK DC pensions and other investments. Do you also tend to liaise with financial planners or accountants based in the EU when helping clients prepare for such a move? I would be very grateful for any wisdom you could share. Thanks again for all the work you put into the podcast, it really does make a difference. Warm regards, Chloe 24:55  Question 5 Hi Pete, Love the podcast.  Very informative and user friendly. I have a question, once popular but maybe not so much now and one that will make advisers sweat again! I'm a sophisticated investor (so to speak!), I manage my own SIPP etc and I'm an accountant so I guess I have a head start over most people.  I have a net worth excluding my house of circa £2.5m spread across a SIPP, ISA, FIC and GIA. I also have an old DB pension.  I'm 59.  It pays out circa £6,500 from the age of 65.  My dad died aged 63.  Given my circumstances I want to transfer the DB scheme into my SIPP.  I have two children so would like them to get it rather than die with me so to speak.  The last transfer value I got was pre covid at circa £100k which I know isn't a brilliant multiple but I'm happy with that.  I'm fit and healthy but I'm not relying on the guaranteed pension given my other pension provisions. So, firstly is it likely the transfer value would have gone up or down given the increase in interest rates and secondly do you think I could get a positive recommendation from an adviser? Thanks, Oscar 31:35  Question 6 Dear Pete and Roger, Love the podcast. I'm a bit more of an adventurous investor than you usually caution, but you provide a certain "passive-tracker-Yin" to my "property-investment-Yang". Given your backlog I'm going to ask you a pension question that I probably don't have to think about for 20 years, so you have time to get to it. I worked in Denmark for several years and paid into a pension scheme while I was there. I believe it is structured similarly to a UK DB pension scheme. There is an initial lump sum plus an income for life.  This pension fund is not covered by QROPS, so there is no transferring my way out of this complexity. The Danish pension fund thinks I'll be paying Danish income tax (presently 37-38%), Chat GPT is adamant that I'll be paying UK Tax. Who's right? If taxed in the UK I can imagine getting the tax free cash allowance right might be complicated. Is there anything else I should be considering? Best Wishes, James

In part two of Ben's conversation with Dr Shyamal Mashru, they unpack what actually makes a good ADHD assessment - and why so many people are still waiting, misdiagnosed, or left without answers.Dr Shyamal, an NHS Consultant Psychiatrist and Medical Lead for Adult ADHD, explains what happens inside a thorough assessment, who is qualified to diagnose ADHD, and why emotional dysregulation is so often overlooked. Together, they explore NHS vs private pathways, co-occurring conditions like autism and RSD, and why ADHD rarely shows up in neat, textbook ways.We hope this episode brings clarity to a process that can often feel stressful, and inaccessible. If you're questioning ADHD, on a waiting list, or trying to understand what good care really looks like, this conversation is for you.Join us at hidden20.org/donate.________Host: Ben BransonProduction Manager: Phoebe De LeiburnéVideo Editor: James ScrivenSocial Media Manager: Charlie YoungMusic: Jackson GreenbergHead of Marketing: Kristen Fuller00:00 Introduction01:12 Who Can Diagnose ADHD in the UK?04:25 ADHD Assessment Options: NHS vs Private Explained11:20 ADHD Assessments Outside the UK: What's Different?13:00 Why ADHD Assessments Are Complex & Often Siloed20:14 ADHD & Reduced Life Expectancy: What the Research Shows24:20 What Makes a Good ADHD Assessment?29:25 ADHD at School vs University: Missed Support32:50 RSD, Relationships & Emotional Regulation Flags34:16 ADHD & Daily Life: Hobbies, Money, Sleep41:02 When ADHD Gets Misdiagnosed - and Why47:15 Autism + ADHD: What If You Suspect Both?55:06 The Missing Piece in ADHD Diagnosis: Emotional Dysregulation59:00 Dr Shyamal's Green Dot BadgeThe Hidden 20% is a charity founded by AuDHD entrepreneur, Ben Branson.Our mission is simple: To change how the world sees neurodivergence.No more stigma. No more shame. No more silence.1 in 5 people are neurodivergent. That's 1.6 billion of us - yet too many are still excluded, misunderstood, or left without support.To break the cycle, we amplify voices, challenge myths, and keep showing up. Spotlighting stories, stats and hard truths. Smashing stereotypes through honest voices, creative campaigns and research that can't be ignored.Every month, over 50,000 people turn to The Hidden 20% to feel safe, seen and to learn about brilliant brains.With your support, we can reach further, grow louder, and keep fighting for the 1 in 5 who deserve more.Join us at hidden20.org/donate.Become a monthly donor.Be part of our community where great minds think differently.Brought to you by charity The Hidden 20% #1203348______________Follow & subscribe…Website: www.hidden20.orgInstagram / TikTok / Youtube / X: @Hidden20charityBen Branson @seedlip_benDr Shymal Mashru @harrowhealthcicHarrow Health offers bespoke NHS community outpatient services across London, plus fast adult ADHD assessment and treatment across England. For more information please visit: https://adhdrighttochoose.com/If you'd like to support The Hidden 20%, you can buy a "green dot" badge at https://www.hidden20.org/thegreendot/p/badge. All proceeds go to the charity. Hosted on Acast. See acast.com/privacy for more information.

Starmer's 'Watergate' moment hits as he refuses to publish the remaining files on Andrew Mountbatten-Windsor. The Green Party says it wants to give free housing, wages and NHS treatment to illegal migrants. Jacob Rees-Mogg joins Jeremy Kyle and former head of Royal security Dai Davies and Royal biographer Andrew Lownie discuss the fall of Andrew whilst Jeremy heads up to Gorton & Denton to look at the close by election race between Reform UK & the Green Party. Hosted on Acast. See acast.com/privacy for more information.

In this episode I speak to global public speaking expert, Dani Wallace. Here she shares how she turned her life around by building a multi-million pound business. Starting her own motivational speaking company with just £300, Dani went from being a struggling mum of 3 who had experienced homlessness and domestic abuse, to organising her own events around the world and has helped over 10 thousand clients to reclaim their voice.    Follow Matt Hall at:  Instagram: https://www.instagram.com/matthallofficial/   Follow Dani Wallace at: Instagram: https://www.instagram.com/thequeenbeedani/?hl=en   BUY YOU TICKETS FOR BUSINESS MASTERY LIVE IN LEEDS HERE:  https://join.successschoolgroup.co.uk/businessmasterylive    This episode is sponsored by Dr. Tania King-Mohammad - The High Ticket Woman, #1 bestselling author of The High Ticket Method, and one of the most sought-after high-ticket sales experts in the game. If you're listening right now, you already know you're built for more. So here's your next move: grab her book The High Ticket Method click here, then head to Instagram @freedomwithtania where she's dropping the kind of strategies and activations that will change the way you sell forever. Dr. Tania King-Mohammad - The High Ticket Woman and your go-to high-ticket sales expert. Go connect with her today, and thank me later.   This episode is also sponsored by Laura Robson and Back Pocket Office. Laura is a systems strategist and certified launch & funnel specialist who helps coaches, consultants and creators build business systems that give them more freedom. Laura is here to help sort all your tech and funnels for your so that you can focus on sales, marketing and delivering... and not have to stress about making sure the tech automations and systems are working. With over 14 years experience of workflow automation in the NHS and healthcare IT, she now brings that expertise to the online business world. Through Laura's signature Strategy–Build–Launch service, she can help you design and build the systems that keep your business running smoothly – from mapping out a clear customer journey to building the tech that supports it. Her approach is calm and collaborative – with a focus on creating beautifully simple systems that give you time back. So if tech has been the thing holding you back, Laura can help you build an online business that works for you. Find out more at www.backpocketoffice.co.uk or connect with Laura on the instagram here.  

Sim Scavazza is NED at London North West University Healthcare NHS Trust, Vice Chair of Imperial College Healthcare NHS Trust and Deputy Chair of the Buckinghamshire, Oxfordshire and Berkshire West NH Integrated Care Board. Listen to this episode to hear about: Leading through a 50% cost reduction (01:05) The human side of cutting costs (03:36) Common mistakes when communicating redundancies (09:36) Creating shared culture after a merger (12:58) The importance of time discipline in high-pressure moments  (17:20) Where boards get inclusion wrong (23:34) How Sim built a portfolio career in the NHS (29:24) How to approach an NHS board interview (33:42) The financial reality of NHS board roles (35:17)⚡The Lightning Round ⚡(39:47)Host: Oliver Cummings Producer: Will Felton Editor: Penelope Coumau Music: Kate Mac Audio: Nick Kold Email: podcast@nurole.com Web: https://www.nurole.com/nurole-podcast-enter-the-boardroom

In this episode of Fitness Business Insights with Matt Robinson, I'm joined by Carly Killen to explore what happens when the traditional fitness career path no longer fits.Carly's journey spans working as an NHS dietitian, transitioning into personal training, building a client base in commercial gyms, moving into private facilities, and ultimately creating a business that aligned with her values, energy, and lifestyle.We talk candidly about the identity shifts that come with career change, why being busy or fully booked doesn't always equal fulfilment, and how many coaches quietly feel trapped by industry expectations they never consciously chose.This conversation covers:The pressure to follow a “standard” fitness career pathBurnout and misalignment in commercial gym environmentsThe hidden cost of chasing growth for growth's sakeWhy adaptability matters more than rigid business modelsBuilding a fitness business around who you are, not who you're told to beIf you're questioning your current version of success, feeling boxed in by the industry, or wondering what comes next in your fitness career, this episode will help you think differently about what's possible.

When it comes to health, award-winning broadcaster and expert medical journalist Dr Deborah Cohen knows what she's talking about. Unlike a lot of people on the internet.  And that's because she puts the work in. Unlike a lot of people on the internet. In a world where wellness influencers and podcast bros hawking wearables and supplements are becoming more trusted than the NHS, Deborah's fascinating book, Bad Influence: How the Internet Hijacked Our Health, is an essential exploration of modern medicine versus 21st century snake oil. Mick was champing at the bit to find out more. As ever, there's extra chat for our £5 and above patreons, and you can find out more about that here. Learn more about your ad choices. Visit megaphone.fm/adchoices

Episode 72 - Alison Gardiner is CEO of Born Digital Health and co-founder of Sleepstation, a digital insomnia program and one of the UK's earliest NHS-adopted digital therapeutics, used across the NHS in England since 2011.Disclaimer: Please note that all information and content on the UK Health Radio Network, all its radio broadcasts and podcasts are provided by the authors, producers, presenters and companies themselves and is only intended as additional information to your general knowledge. As a service to our listeners/readers our programs/content are for general information and entertainment only.  The UK Health Radio Network does not recommend, endorse, or object to the views, products or topics expressed or discussed by show hosts or their guests, authors and interviewees.  We suggest you always consult with your own professional – personal, medical, financial or legal advisor. So please do not delay or disregard any professional – personal, medical, financial or legal advice received due to something you have heard or read on the UK Health Radio Network.

Dr. Brick Lantz of the Christian Medical and Dental Association addresses the recent move by the UK's NHS to cancel a study on of the effects of puberty blockers on children due to ethical concerns.  The detransition movement is growing.  How do we offer hope to those who were swept up by gender ideology?  Musician and author Michael Charles Olson, author of "Daddy Set the Church on Fire," talks about the brokenness of his family growing up, and how he found restoration through Christ.  The Reconnect with Carmen and all Faith Radio podcasts are made possible by your support. Give now: Click here  

Episode 112How to secure the right mentor. A leader's guide to getting a yes.EPISODE DESCRIPTION Mentorship can accelerate your leadership growth, sharpen your thinking, and expand your perspective but how do you actually secure the right mentor?In this episode of The Lonely Leader Podcast, James Rule moves beyond the “why mentorship matters” conversation and dives into the practical strategies leaders need to confidently approach, engage, and build meaningful mentor relationships.Wanting a mentor is easy. Earning a yes from the right one requires intention, clarity, and skill.KEY TAKEAWAYSHow to identify your true leadership development gaps.The right way to approach a potential mentor.How to prepare for conversations that impress, not waste time.The behaviours that earn trust and follow up meetings.How to handle rejection with confidence.Simple follow up strategies that build lasting relationships.EPISODES TO CHECK OUT NEXTEpisode 67 - Accelerated Learning: How mentorship fuels your leadership journeyEpisode 57 - Lessons from my leadership journey (Part 1)Episode 58 - Lessons from my leadership journey (Part 2) ABOUT THE HOST James is an experienced mentor, coach and thought leader who works with a range of clients from FTSE 100 companies, SME´s the NHS and wider public and not for profit sectors.His twenty year career in elite sport initially as a professional rugby player but predominantly as a chief executive has given him an invaluable insight in managing the success, failures and pressures associated with leadership at the highest level.As a high performance coach James specialises in enhancing resilience and leadership development. He is a passionate advocate of the notion that to find lasting fulfilment we need to take a holistic view of high performance. CONNECT & CONTACT Website www.thelonelyleader.co.ukThe Lonely Leader's LinkedIn James' LinkedInInstagramEmail: hello@thelonelyleader.co.uk NEWSLETTERSign Up to The Leadership Accelerator Newsletter for advice, inspiration and ideas, you'll also receive James' Tackling Imposter Syndrome guide.THIS SHOW WAS BROUGHT TO YOU BY LONELY LEADER MEDIA Hosted on Acast. See acast.com/privacy for more information.

El número de personas que esperan atención hospitalaria

Irish author Marian Keyes has sold over 30 million copies of her books worldwide over the past three decades. From her 1995 debut Watermelon to Rachel's Holiday and last year's 'menopause romance' My Favourite Mistake, she's championed telling ordinary women's stories in all their glory, with plenty of humour thrown in. Now some of her most-loved books and characters have been adapted into a TV series called The Walsh Sisters which has just debuted on BBC One and BBC iPlayer. Marian and the show's co-creator Stefanie Preissner talk to presenter Nuala McGovern about bringing Rachel and her sisters to life on screen. As the Government prepares to unveil its plans for a major overhaul of the SEND system, we hear from BBC Political Correspondent Alex Forsyth on what's been said so far and what's expected. The government has said it will spend billions to make English mainstream schools more inclusive for pupils with special educational needs and disabilities, with Sir Keir Starmer saying that the experience of his late brother, who had learning disabilities, makes him "determined to change Britain so that it is truly built for all." The number of people with education, health and care plans (EHCPs) up to the age of 25 in England has doubled in a decade. Student midwives have contacted us to say many of them are struggling to find jobs despite a serious shortage of midwives in the NHS. A new survey from the Royal College of Midwives echoes that finding. It says 31% of those newly qualified midwifes are still not employed in the role and the majority of those who have found employment are on fixed term contracts. This comes a year after the government announced it's Graduate Guarantee pledging that every newly qualified nurse and midwife in England would have the opportunity to apply to join the NHS workforce. We hear from Safia, who is in her final year of midwifery training, and Gill Walton, Chief Executive of the Royal College of Midwives. Award-winning British Nigerian fashion designer Tolu Coker joins Nuala in the studio fresh from kicking off London Fashion Week with King Charles in the front row. Her latest collection, Survivor's Remorse, is inspired by grief, nostalgia and childhood memories and is a joyful celebration of growing up in 1990s London and the community that shaped her. Presenter: Nuala McGovern Producer: Sarah Jane Griffiths

Trigger Warning - Pregnancy after loss. In this episode, Alex returns to the podcast (last seen S8 E16) to talk openly about life after loss. She shares her experience of recurrent miscarriages and what it was really like to step back into pregnancy carrying grief, fear, and hope all at the same time.Alex reflects on the emotional toll of trying again - the constant worry, the anxiety that never quite switches off, and the careful ways she learned to protect herself while still allowing room for hope. She speaks honestly about the coping strategies that helped her get through the hardest moments, and how vital support from others was when everything felt overwhelming.This conversation is a reminder that pregnancy after loss is rarely straightforward. It's about finding balance, holding onto small positives, and allowing yourself to feel everything - without guilt or expectation.

In this week's episode of the Seven Figure Consultant Podcast, we're doing something a bit different! My guest Sharath Jeevan, Founder of The Generational Success Lab at Oxford's Said Business School, is interviewing me as we approach the one-year anniversary of my book 'Too Much'. If you've ever felt like your ambition was 'too much' for the world around you, or if you left corporate because you needed a bigger playing field to run on, this conversation is for you. Sharath and I explore how I went from a rebellious teenager who wanted to be a rock star to building a seven-figure consulting business that finally gives me the container I need.  We talk about the corporate exit, the early days of celebrating £3,000 months, and what it really takes to build a business around your zone of genius rather than what you think you're 'supposed' to do.  This is a candid conversation about legacy, ambition and what happens when you finally stop trying to fit into someone else's version of success. In This Episode:  [00:01:33] How Jessica's early ambition and 'too much-ness' shaped her path - and why entrepreneurship became the only container that could hold her [00:05:16] The violin, physics homework, and parental expectations: navigating the gap between what your family wanted and who you actually are [00:10:22] The corporate years at Sony and the moment Jessica realized she'd rather be made redundant than stay - and what came next [00:17:50] Building a £3,000/month business from the attic and how Jessica's husband became her biggest supporter [00:22:49] The pivot moment: when Jessica stopped trying to 'follow the business plan' and started listening to what clients actually needed [00:27:14] Getting past comparisonitis and imposter syndrome and why one client sale fixes most business problems [00:29:34] Reflecting on the book 'Too Much', writing as legacy work, and what's next Key Takeaways:  Entrepreneurship was the only container big enough: If you've always felt restless in corporate, it's not because you're broken. You just need a playing field where you can run as fast as you want without hitting a ceiling. The power of low-volume, high-ticket consulting: One client sale can fix most business problems. Five clients can fix almost everything. This is why we build businesses where you're not making 500 sales just to stay afloat. Your ambition isn't the problem. The context is: Jessica spent years being told she was 'too much'. The breakthrough came when she stopped trying to fit into someone else's version of success and built a business aligned with her actual genius. Quotes:  "Entrepreneurship has been the only thing that I found, the only container that can actually hold me, that doesn't make me feel kind of trapped or restricted and gives me a big playing field where I can run as fast as I want." - Jessica Fearnley "I always try and go with the path of least resistance, keeping the bar as low as it can possibly be, because then it's like, I may as well have a go. And you know, more often than not it goes well and it works." - Jessica Fearnley "I'm really passionate about how we can be intentional about our legacy. You've done that very consciously and deliberately, and I'm very passionate about how we can all try and find that whatever way makes sense for us in our lives as well." - Sharath Jeevan Useful Links Sharath Follow Sharath on LinkedIn Sharath's Website: intrinsic-labs.com Episode 112: Encouraging Yourself to Make a Bigger Impact with Sharath Jeevan Jessica: Buy Jessica's book, Too Much, on Amazon Get in touch with Jessica to discuss your consulting business Leave a rating and review for the Seven Figure Consultant Podcast Connect with Jessica on LinkedIn Guest Bio Sharath is focused on helping Leaders across sectors futureproof success and build intentional legacy, with clients ranging from L'Oreal to the Barbican to the NHS. He's established the Generational Success Lab at Oxford University's Said Business School, where he's exploring how generations can collaborate better to shape a better world. He's the author of two acclaimed leadership books, "Intrinsic" and "Inflection". Sharath is exploring the questions of generational transition through a forthcoming novel and comedy show.

Over the past decade, thousands of families say they have been failed by England's maternity services. With a review into 12 NHS trusts due to publish its interim findings this week, we hear from some of those affected. What went wrong? And can future tragedies can be prevented?This podcast was brought to you thanks to the support of readers of The Times and The Sunday Times. Subscribe today: http://thetimes.com/thestoryGuest: Poppy Koronka, health correspondent, The Times.Host: Luke Jones.Producer: Shabnam Grewal. We want to hear from you - email: thestory@thetimes.comIf you've been affected by any of the issues raised, the following organisations may be able to help:Sands is a UK charity that provides support to anyone affected by the death of a baby. Please visit www.sands.org.uk or call the helpline on 0808 164 3332The Birth Trauma Association is a charity that supports women and families who have experienced traumatic birth. Visit www.birthtraumaassociation.org or call the helpline on 0203 621 6338Tommy's is a charity focused on pregnancy research in the UK. Visit their website www.tommys.org or call 0800 0147 800Read more: NHS maternity failings leave women feeling blamed for poor careClips: Parliament TV, Channel 4 News, Ockenden Maternity Review, Sky News,Photo: Getty Images.This podcast was brought to you thanks to subscribers of The Times and The Sunday Times. To enjoy unlimited digital access to all our journalism subscribe here. Hosted on Acast. See acast.com/privacy for more information.

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into the dynamic landscape of these industries, exploring significant regulatory shifts, scientific breakthroughs, and strategic corporate maneuvers that are shaping the future of healthcare.The pharmaceutical and biotech sectors are currently navigating a period of profound transition. Recent regulatory developments have captured attention, particularly the U.S. Supreme Court's decision to overturn emergency tariffs imposed by the previous administration. This ruling is pivotal as it alleviates financial pressures on the industry, allowing companies to redirect their resources towards innovation and development. It underscores the interconnectedness of global supply chains and highlights the importance of stable regulatory environments for fostering industry growth.In a notable advancement within oncology, AstraZeneca has achieved FDA approval for its combination therapy of Calquence and Venclexta as an all-oral regimen for first-line chronic lymphocytic leukemia (CLL). This approval not only positions AstraZeneca competitively in the BTK inhibitor market but also signifies a shift towards more patient-friendly treatment regimens. By simplifying therapy, this development promises to enhance patient compliance and improve outcomes, challenging existing standards in CLL care.Meanwhile, internal challenges at the Centers for Disease Control and Prevention have led to a postponement of a critical vaccine advisory panel meeting. This delay occurs amid evolving vaccine policies that have sparked debate within the public health community, potentially impacting immunization strategies and initiatives aimed at bolstering public health.Corporate governance within the industry is also experiencing shifts. Novo Nordisk has nominated two industry veterans to its board as part of an ongoing strategy to align leadership with evolving business objectives. Similarly, Roche is contemplating divesting its once-blockbuster antibiotic Rocephin in response to competitive pressures from generics in Europe. These moves reflect a broader industry trend where companies are re-evaluating their portfolios to better respond to market dynamics and patent expirations.Novartis is making strategic changes as well by selling its stake in Novartis India Limited while maintaining separate commercial and R&D interests in the region. This action highlights a growing trend among pharmaceutical giants towards streamlining operations and focusing on high-growth areas—a strategy aimed at maximizing resource allocation efficiency.Despite narrowly missing a $1 billion revenue target for 2025, Madrigal Pharmaceuticals remains optimistic about the growth prospects of its drug Rezdiifra within the metabolic dysfunction-associated steatohepatitis (MASH) market. The company anticipates further expansion driven by unmet medical needs, underscoring the competitive dynamics within this therapeutic area.In personnel movements that could influence strategic directions, Daiichi Sankyo has appointed former Novartis CMO John Tsai as head of its R&D division. His expertise is expected to bolster Daiichi's focus on oncology and other critical therapeutic areas, potentially accelerating innovation within their drug development pipeline.Meanwhile, Manus Bio has secured a $15 million contract with the U.S. government for domestic supply of shikimic acid, an essential component for producing Tamiflu. This contract highlights efforts to strengthen domestic pharmaceutical supply chains amid global uncertainties—a crucial consideration for ensuring medication availability during crises.In clinical research, a setback was observed with Grail's Galleri cancer blood test trial failing to meet its primary endpoint in collaboration with the NHS. The resulting decline in GrailSupport the show

Welcome to Insurance Covered, the podcast that covers everything insurance.In this episode, Peter Mansfield interviews Lewis Davies, a Senior Development Underwriter specialising in medical malpractice insurance. They explore the intricacies of medical malpractice, including its definition, types of claims, and the roles of various healthcare professionals. The conversation delves into who purchases medical malpractice insurance, the coverage provided, and the implications of claims on both patients and medical professionals. They also discuss the NHS's role in the UK healthcare system, the impact of social inflation on claims, and future trends in the industry, particularly regarding AI and its potential implications for malpractice insurance.We hope you enjoyed this episode, if you did please subscribe to be notified when new episodes release. Hosted on Acast. See acast.com/privacy for more information.

In this week's episode we return to the New Hospital Programme - still one of the most ambitious public infrastructure programmes the UK has seen in decades. The last time I was in NHP's Waterloo office in London was for episode 143 just before Christmas. Then I spoke to Emily King and Doug Baldock about the scale and urgency of the challenge to replace ageing and unsafe hospital infrastructure, and the shift towards industrialised construction through the £37bn Hospital 2.0 programme.Today, we're going deeper into the “how”. Because £37 billion of ambition only becomes reality if the market can actually deliver it.To do that I am joined by Emma Whigham, Alliance Director for the NHP Alliance, and Rick Lennard, Chief Operating Officer for the New Hospital Programme. Together, they're at the sharp end of designing and procuring the Hospital 2.0 Alliance - the new commercial and delivery model intended to underpin the programme for the next 12 years.This is about more than building hospitals. It's about reshaping how the NHS works with industry, creating a stable pipeline that gives suppliers the confidence to invest in skills, manufacturing capacity and modern methods of construction. It's about standardisation without stifling innovation. And it's about learning from decades of fragmented delivery to create something more programmatic, predictable and collaborative.So let's crack on and explore how the Alliance is structured, what early market engagement has changed, where the market pushback really is - or is likely to be. ResourcesNew Hospital Programme: Plan for ImplementationGovernment hospital investment press release Hospital 2.0 AllianceSupplier Guide.Egan review 1998Latham review 1994

Rosamund Pike, the Emmy and Golden Globe winner, is known for standout roles in Saltburn, her Oscar nominated lead in Gone Girl, and Made in Dagenham. Next month she stars on the West End stage, coming back to the role of Jessica Parks, the maverick judge at the heart of the National Theatre's hit play Inter Alia, also filmed for NT Live screenings. She joined Anita Rani to discuss her role that explores motherhood, masculinity and the complexities of justice.It's more than a decade since Nadiya Hussain became a household name after winning the Great British Bake Off. Since then, she's fronted her own cookery shows, written more than a dozen cookbooks and a series of children's books. Her latest collection of recipes is called Quick Comforts, and Nadiya joined presenter Clare McDonnell to talk about finding comfort in food, her career so far and lots more.In December 2024, Dominque Pelicot and 46 other men were found guilty of the aggravated rape of his wife Gisèle. Another two were found guilty of attempted rape and a further two were found guilty of sexual assault. Dominque had drugged Gisèle with medication without her knowledge, raped her and invited other men to rape her, filming as they did so. At least another 20 men who took part in these rapes could not be identified. Waving her right to anonymity, Gisèle Pelicot declared that shame has to change sides. Despite her becoming a household name, not only in her native France but around the world, very little was known about Gisèle herself. She has written her memoir, A Hymn to Life, with writer Judith Perrignon and Judith joins Nuala McGovern to discuss.Dr Punam Krishan is a Glasgow based NHS GP and the resident doctor on the BBC's Morning Live programme. Back in 2024 she was a contestant on Strictly Come Dancing where she was the first dancer to perform a Bollywood routine. But six months ago, at the age of 42, she was diagnosed with breast cancer, and has since gone through treatment. She has recently written about how being a doctor didn't prepare her for the experience of being a patient. Dr Punam joined Anita to discuss.Ketamine has become a worryingly popular recreational drug among young people, and the consequences can be devastating. That's according to a specialist NHS clinic which reports that some teenagers suffer such severe bladder damage from taking it, that some rely on incontinence pads. To discuss the implications, Anita was joined by Dr Alison Downey, Consultant Urologist at Mid Staffs NHS Foundation Trust, who is treating young people with ketamine related bladder problems. Also joining them is Eva, who has stopped using ketamine and is receiving support from the hub.The award-winning internationally renowned Welsh harpist and composer Catrin Finch first came to prominence in her early 20s as the official Royal Harpist to King Charles, the-then Prince of Wales. She achieved chart success with her No. 1 recording of Bach's Goldberg Variations and has performed with many of the world's leading orchestras. Catrin, who began playing the harp at just six years old, has a new album, Notes to Self, a series of reflective and deeply personal new tracks she has composed for Katy, her 13-year-old-self. She joined Nuala and performed live in the studio. Presenter: Anita Rani Producer: Annette Wells

Rosamund Pike, the Emmy and Golden Globe winner, is known for standout roles in Saltburn, her Oscar nominated lead in Gone Girl, and Made in Dagenham. Next month she stars on the West End stage, coming back to the role of Jessica Parks, the maverick judge at the heart of the National Theatre's hit play Inter Alia, also filmed for NT Live screenings. She joins Anita Rani to discuss her role that explores motherhood, masculinity and the complexities of justice. Ketamine has become a worryingly popular recreational drug among young people, and the consequences can be devastating. That's according to a specialist NHS clinic which reports that some teenagers suffer such severe bladder damage from taking it, that some rely on incontinence pads. To discuss the implications, Anita is joined by Dr Alison Downey, Consultant Urologist at Mid Staffs NHS Foundation Trust, who is treating young people with ketamine related bladder problems. They are also joined by Faye Maloney, Director of The Lifeboat Recovery Community Hub, along with Eva, who has stopped using ketamine and is receiving support from the hub. The American writer Madeline Cash has just published her debut novel Lost Lambs — already an instant bestseller — and she's only 29. She won high praise from Lena Dunham, who has called her ‘a voice like no other'. Lost Lambs follows the Flynn family — parents Bud and Catherine and their three teenage daughters — whose decision to open their marriage plunges the household into chaos. As the Winter Olympics comes to a close, BBC sports reporter Katie Falkingham joins Anita to discuss the standout female athletes and record breaking performances.Presenter: Anita Rani Producer: Dianne McGregor

Show NotesWhat happens when anthropology turns its gaze on psychology and coaching?In this episode, Simon Western is joined by social anthropologist Dr Mikkel Kenni Bruun and social scientist Dr Rebecca Hutten to explore what sits beneath contemporary mental health, therapy, and coaching practices. Together, they discuss culture, power, and the often-invisible assumptions shaping therapeutic work.Rather than treating psychology as universal or value-neutral, Mikkel and Rebecca show how it is culturally produced, shaped by specific histories, institutions, and ways of making meaning. From this perspective, therapy and coaching are never neutral; they are embedded in social, political, and moral worlds.Ethnography is central to this conversation, not just as a research method, but as a way of listening and staying with complexity. Instead of forcing distress, healing, and care into predefined psychological categories, ethnography attends to how these experiences are actually lived across contexts.The discussion also challenges dominant Western ideas of the self. While psychology and coaching often centre the autonomous individual, anthropological perspectives highlight relational and socially embedded selves. This raises urgent questions about what happens when Western therapeutic models travel globally - and what they may erase or misunderstand.Cultural competence comes under scrutiny too. Often presented as a solution, it can risk flattening culture into tidy checklists rather than engaging with lived complexity and power. As psychological language increasingly shapes public policy, workplaces, and everyday life, anthropology helps reveal the cultural and political work happening beneath the surface.Key Takeaways Psychological and coaching practices are culturally produced, not universal Therapeutic cultures vary across histories, institutions, and contexts Ethnography reveals how mental health is actually lived The individual self is not a universal model Cultural competence can oversimplify difference Psychological practice is fundamentally relational Mental health discourse shapes ideas of the “good life” Anthropology makes the familiar strange - and visible again KeywordsAnthropology, psychology, coaching, mental health, therapeutic culture, ethnography, cultural competence, relationality, self, good lifeBrief BiosDr Mikkel Kenni Bruun is a social anthropologist at the University of Cambridge, Research Associate at the Healthcare Improvement Studies (THIS) Institute, and Affiliated Lecturer in the Department of History and Philosophy of Science. His ethnographic research includes NHS Talking Therapies (IAPT) services and community mental health initiatives in the UK. He is co-editor of Towards an Anthropology of Psychology (2025) and Rhythm and Vigilance (2025).Dr Rebecca Hutten is an independent researcher, social scientist, and Associate Lecturer at The Open University. Trained as an anthropologist, she has worked in government policy research and Public Health at the University of Sheffield, and brings extensive fieldwork and clinical experience within NHS psychological services. She is co-editor of Towards an Anthropology of Psychology (2025).

Dr. Stuart Grant, founder of Archetype Medtech, shares his journey designing and delivering breakthrough orthopedic and surgical innovations across the UK, US, and China. Stuart recounts how an early internship led him into medtech, what kept him there, and how building the ASPAC Innovation Center in China helped accelerate a total knee instrument system that dramatically reduced time to market. He explains the leap from corporate leader to entrepreneur: planning for years, earning a PhD in Medtech Product Innovation, and building a consultancy that helps startups and scale-ups turn early clinical unmet needs into market-ready, regulator-approved devices through a network of experts and an “expertise for equity” model.    Guest links: https://archetype-medtech.com/  Charity supported: Sleep in Heavenly Peace Interested in being a guest on the show or have feedback to share? Email us at theleadingdifference@velentium.com.  PRODUCTION CREDITS Host & Editor: Lindsey Dinneen Producer: Velentium Medical   EPISODE TRANSCRIPT Episode 074 - Stuart Grant [00:00:00] Lindsey Dinneen: Hi, I'm Lindsey and I'm talking with MedTech industry leaders on how they change lives for a better world. [00:00:09] Diane Bouis: The inventions and technologies are fascinating and so are the people who work with them. [00:00:15] Frank Jaskulke: There was a period of time where I realized, fundamentally, my job was to go hang out with really smart people that are saving lives and then do work that would help them save more lives. [00:00:28] Diane Bouis: I got into the business to save lives and it is incredibly motivating to work with people who are in that same business, saving or improving lives. [00:00:38] Duane Mancini: What better industry than where I get to wake up every day and just save people's lives. [00:00:42] Lindsey Dinneen: These are extraordinary people doing extraordinary work, and this is The Leading Difference. Hello, and welcome back to another episode of the Leading Difference podcast. I'm your host Lindsey, and today I'm delighted to welcome Dr. Stuart Grant. Dr. Grant is a chartered engineer and the founder of Archetype Medtech, a consultancy and innovation studio helping medical device startups and scale ups transform early clinical, unmet needs into market ready products. With nearly 25 years of experience, Stuart has led global teams across the UK, US, China, and emerging markets delivering breakthrough innovations in hip, knee, shoulder, and trauma surgery. A highlight of his career was establishing the ASPAC Innovation Center in China, where he built R&D capability from the ground up and launched a pioneering total knee instrument system that dramatically reduced time to market. Passionate about advancing medical technology and mentoring future engineers, he bridges creativity, engineering, and regulation to accelerate safer, smarter medtech innovation worldwide. All right. Welcome to the show. It's so great to have you here today. Thanks for joining me. [00:01:57] Stuart Grant: It's lovely to be here, Lindsey. [00:01:58] Lindsey Dinneen: Yeah. Excellent. Well, I was wondering if you could start by sharing a little bit about yourself, your background, and what led you to medtech. [00:02:08] Stuart Grant: Yeah. So, I was actually, I'm obviously, as you can tell from my accent, I'm British, but I was born in Germany because my, my dad was in the military in the 1970s when I was born. So I was born actually in Berlin, which is quite interesting to be a place to be, grew up in. So I traveled around a lot here in the UK, in Germany with my dad getting posted everywhere. My mom's a nurse. So I was in medtech, not really knowing I was in medtech as a kid, but I, my family was, so yeah. And then obviously went to school, all the places I was at university. I went to university to do product design, and my goal was to be a product designer, a cool product designer, designing fancy products like Johnny Ive. And when I was looking for a job as a co-op, or an intern as you call them in the US, I was just really unsuccessful finding a job. I was doing a lot of interviews, getting turned down, sending my CV out a lot, and j happened just to advertise on the Board of University, and it said Johnson Orthopedics and no one really knew what that was in. And none of my fellow students at applied because they thought it would be designing baby bottles for putting talcum powder in and shampoo in and stuff like that. So they're like, "I'm not doing that job." So I desperately applied for it and luckily found out about all this medtech, and I've been here doing medtech for 25 years. So they gave me a job. I had to work hard to keep the job and get reemployed over and over again. But yeah, joining originally Johnson Orthopedics a long time ago is how I found out about medtech. I never knew when I was 18 that really it was a thing that existed. [00:03:47] Lindsey Dinneen: Yeah. So, okay. So you thought product design, and then when you got into medtech, what were some of the things that attracted you and that actually compelled you to stay and make a career out of it? [00:04:00] Stuart Grant: Ha. So I was a young guy with the student debts. What compelled me, I was getting paid to stay, but not to be too flippant about it, but, you know, when I was doing this engineering and design work in my early days in the CAD system, it was just so interesting. I was designing these products that were going into people or the instrumentation to make help the surgeon and going to these ORs and watching the surgeon do their job and trying to figure out how how I can make it better from their input was really interesting. I could apply it straight away, basically. In the early two thousands, there wasn't all these regulations and standards that slowed you down. So you could go and design an instrument, get it machined in the machine shop, get it clean, take it to the surgeon, he can use it, you know, probably be frowned upon 25 years later. But that's what we used to do and really adapt. And probably more interesting than going into product design and fast moving consumer goods where you're designing a, a kettle or a toaster or something, a plastic casing. It was actually much more interesting to do that. And I stayed because I spent four years here in Leeds, in the UK, was getting a bit bored and wanted to find something else to do, and then an opportunity came up in the US. So I moved over to Warsaw, Indiana, the orthopedics capital of the world, as you might know it. Worked there for, stayed there for seven years. Really enjoyed it.. People sort of bemoan Warsaw for being in the sticks in just a bunch of cornfields around it. But I enjoyed it. It's got, we had a good bunch of young friends there. I was in late twenties, early thirties at the time. There was Noah and Spikes. You'd go for a drink and some nice food. It was all right. I enjoyed my time and after that I was, after seven years, I was like, "Okay, what do I do next?" And I was looking around for jobs in medtech. Then another opportunity came up in and we were looking for people to go over and help set it up, train the staff on what MedTech product development was. And so I jumped to the chance and spent five years living in China, in Shanghai. After five years is your limit, so I had to come home. I couldn't stay. I wanted to stay, but they wouldn't allow me to. So, so I came back to the UK. And then started MDR for five years as leading the Joints MDR program, which was lots of fun, as you could probably tell, wasn't really R&D, was a lot of leadership and project management and dealing with a lot of people and a lot of problems on a day-to-day basis. And so, yeah, after that I I left J&J about three years ago and started my own product development agency. And we can talk about a little bit about that later. So that's where I am and where I got to. [00:06:50] Lindsey Dinneen: Excellent. Yeah, I definitely wanna talk about that as well. But going back a little bit-- and perhaps this is actually something that's occurred since you started your own company as well-- but are there any moments that really stand out to you along your journey of affirming that, "Hey, yeah, I actually am in the right place, in the right industry?" [00:07:12] Stuart Grant: That's a really hard one is sort of the, is the grass always greener somewhere else, type of question. Right? I guess compare, you shouldn't compare, but comparing to my friends at my university, my product design and what they've done and what I've done they've moved into the car industry a lot. Went to the car development and car industries always had its ups and downs and its problems. And you know, they've had some really cracking jobs working for McLaren and Ferrari and you know, but I think just the interesting things that medtech do that nobody really knows about is really what keeps me moving along and having conversations with people when they, you tell them like, "I used to design hips and knees and shoulders and things like that," and they're like, "Oh, my mother's got a hip and knee" and blah, blah, and you really talk about it. Actually, my mother does have a hip now and she's going in a couple months time to get the other hip done. I do know what brand she's got, so. [00:08:10] Lindsey Dinneen: See, that's really cool. Yeah. Okay. So, so, on your LinkedIn I noticed that you describe yourself as a fixer, a challenger, and a change maker, which I love. But I'd love to hear from you exactly what you mean by all those things as you have developed in your career, and now as you're doing, of course, your own consulting. [00:08:34] Stuart Grant: Yeah, so in Johnson and my colleagues are probably, I agree with this, I had a bit of a reputation of getting the more difficult projects. The, that's probably why I got MDR in the end 'cause I would always get the projects that had problems and I enjoyed that. I liked digging deep and solving the problem and wrangling everyone together and pushing everybody along to help. And that was actually one of the reasons why I moved to the US 'cause the original project I moved to was the project leader left and it was in a bit of a shambles. So I went over to sort of, sort of try and get it together and just ended up staying and working on multiple projects. So I like that. Really challenging, not just the engineering side. The engineering side is obviously really interesting, but the challenging project management and people management and process management in a big corporation, all of those things, people, product, process, all come together just to cause a big headache sometimes, you know, herding cats as say and going, trying to solve those problems as an engineer, always trying to solve these problems, right? So it's you're always trying to figure out how you can move forward. [00:09:52] Lindsey Dinneen: Yeah. Yeah, absolutely. So, okay, so that kind of brings us to the company. So what was it like going from employee to entrepreneur? Were you, did you feel ready and prepared for that leap? Or what has that transition and pathway been for you? [00:10:10] Stuart Grant: So I've, I was a long-term planner. I was planning for this for five years whilst I was working for Johnson. So I went and got, when I came back to the UK I started my PhD and I knew getting a PhD was a real way of building credibility immediately, right? Before you step in a room and have a conversation with you, if you've got a PhD in the subject you're about to talk about, people pay attention, hopefully. Right? So I did my, so I did my PhD in Medtech Product Innovation, what the process is. So I spent seven years part-time working for Johnson, getting my PhD, knowing that eventually in my mid forties, there'll be an inflection point, which usually isn't people in big corporations, right, that either stay to the end for until you're six, mid sixties. If you hit 50, usually stay for the next decade, right? Or you leave and do something else. And I was like, "Okay, 45, I'm gonna pull the bandaid, go in, get my PhD, set up my own company plan, get the plan to do it, get the savings," and so I was working on MDR and a new MDR was coming to an end, and then they'd have to find me a new project, which probably didn't exist. So I also knew that J&J would be like, "Ah, Stuart, you've been here for 23 years. There's not really anything of your level here." I'd be like, "Great, let's go." So this was all a, you always it's a big step, right? I have a family. I can't just sort of walk in, not come in the office anymore. So it was a big plan that my wife and I had for quite a number of years to execute. So it's still a struggle. I've been doing it for three years. It's still hard work, still building the company, finding clients, understanding what their pain points are and improving your picture and all those other things, still is still a challenge, but it's a new challenge. [00:12:06] Lindsey Dinneen: Yeah. [00:12:07] Stuart Grant: And as I say, as I said, when people worry about the risk, it's like I can easily just go and get a corporate job again as a move back and have all this new relevant experience. So it's a risk, but you have to balance that by the benefits. [00:12:21] Lindsey Dinneen: Yeah, calculated risk that you've planned for, so good for you. So, okay, so tell us a little bit about your company now and who you help and kind of where in the development or even ideation process that you can come in and really make a difference. [00:12:40] Stuart Grant: So, yeah, so Archetype MedTech is a product development, product innovation agency. And what we do, we usually work with startups or scale ups. Startup side, they'll have a proof of concept. They've already defined the unmet clinical need. They've sort of wrangled the technology and validated the actual technology does what it they're trying to make it do, but they just dunno how to make this a medical device product, right? They've they've got the technology, but they dunno how the product make a product that's sellable is releasable and it gets approved by FDA or here in the, i'll say here in the EU, I know I said in the UK, but MDR and I help them work out that product innovation strategy. So take them all through either they need to do the frontend innovation and understand their needs and the insights and the business case, and then the engineering requirements and specifications. The design and engineering part I help them with, and this is not just me. I have a network of experts, a sort of consortium of experts that come together and bring all these different specialties and then we help them with the testing, what testing they need to do, their risk management, usability, all that fun stuff. And then contact and help them work with the manufacturers. So contract manufacturers, then their regulatory approval. So really what we try to do is, 'cause we're bringing all this expertise as a group of people together, the entrepreneur, usually a salesman or surgeon at this point, who may be a university spin out, can spend a lot of time and money trying to find these experts, trying to find these resources, trying to understand the product development, the MedTech product development process, which is all written down in various books, but when you get down to the details, it gets really complicated. So what we do is help them go through that as fast and as efficiently as a possible, so they're not wasting capital fishing around for those experts. We already have that network of experts that we can bring in and take them through the process as quickly as possible. So that's what Archetype Medtech do for our clients. And has been successful. We have quite a number of clients, mostly in orthopedics and surgical 'cause that's my specialty in medtech. And what we also do, we just don't want to be a management consultancy firm. Well, we do if it's right, we share what we call expertise for equity. So we'll take some equity from the company, but we'll cut our day rates or maybe do it for free, do and help them go through the process as quickly as possible. That means we've got skin in the game, right? We're not just taking their money and going, "Great. This is great. Good luck on the commercialization. Not our problem." [00:15:29] Lindsey Dinneen: Right. [00:15:30] Stuart Grant: It is our problem. 'cause we want a return on our risk and our investment as well. So, yeah, that's what we try to do. And along with that we do a load of pro bono work with surgeons in the NHS who have had ideas. We help them just get their idea a bit further along so they can start looking for funding and investment, and I can share that with you later 'cause it's a really important program that the NHS run it. If there's any mentors out there that want to get involved I can point them in the right direction. [00:16:00] Lindsey Dinneen: Actually that's fantastic and I would love to hear a little bit more about the organization and yeah, how people can get involved and help and what do they all do. [00:16:10] Stuart Grant: Yeah. So the NHS have set up this called NHS Clinical Entrepreneurs Program. This is not my company. This is a completely separate organization. And what it is, clinicians, anybody who works in the NHS-- you know NHS is a 1.6 million people who are employed in the NHS. It's a massive company organization. They come up with clinical needs 'cause they're in the problem and they start working out how they solve it, even through medical device or health tech or an app or anything, right? And they can go into this, it is basically the equivalent of an accelerator program over about nine months. And we have mentors like myself who work with those clinicians to help them develop their idea. So I've got a couple of clinicians that I work with. One is developing a neurosurgical device for helping him cut out tumors in the brain. At the moment, they use two tools. They use a scalpel and a cordy, a bipolar cordy, and they're very basic tools. And what he has to do, he's under a microscope, and he has to swap these one by one, does this scalpel to cut the vascularization of the tumor. Then he has to seal it. And he has to pass the nurse has to pass in these tools and he can't see a, see the nurse passing him. So he is like, "Can I develop a tool that's in one a scalpel and a bipolar" so he doesn't have to keep changing the tool in his hand? And you can know by the cognitive load and changing that tool in the field that these surgeries take eight to 12 hours to cut out a tumor from the brain. So he's saying every, he swaps his tool about 200 times and it takes three seconds. So you can start doing the maths. [00:17:59] Lindsey Dinneen: Yeah. [00:18:01] Stuart Grant: Yeah. And then the other, so the other is a doctor, actually, the doc is a neonatal doctor and he's trying to develop a langoscope for neonatal babies. The langoscopes at the moment haven't really improved in the last 60 years. The Muller blades, they're called, and they're the stainless steel things that basically adult ones have been shrunk down to baby size and changed a little bit. They're not very good. And when you've got a newborn baby who's struggling to breathe, the mother's there obviously upset, so the father's probably there and you're trying to get langoscope down their throat, it's not a great, it is a very stressful situation, so he's kind of developed a, trying to develop a better one, right? Even the simple things. These things are made of stainless steel and you put a piece of metal on a baby's tongue. A newborn baby's obviously never experienced cold before, so they obviously start freaking out and squirming and you're trying to get this thing down her throat. It's crazy. So I'm helping him to see if he can come up with a better solution. He's got a, got an idea at the moment. He's developed some prototypes and we're gonna help him get it, see if we can get it a bit further along, and hopefully get to the market and solve this real small unmet clinical need, but really important one. [00:19:16] Lindsey Dinneen: Yeah. That's incredible to hear about both of those stories. That is really exciting. I love I-- this is partly why I love this industry so much is the innovation coming out of it is always amazing. People care so deeply about making a difference and improving patient outcomes, and then to hear about those kinds of innovations, ugh, that's awesome. [00:19:38] Stuart Grant: Yeah. Yeah. So if there's any experts out there listening who wanna get involved in the N-H-S-C-E-P program, I know Australia does one too. So yeah, get involved and share your knowledge freely to some clinicians who wanna, who have found an unmet clinical need and wanna solve it, but don't know how to. [00:19:56] Lindsey Dinneen: Yeah. Love it. That's fantastic. So it, it seems like, you know, from your career trajectory and your continuing education all this time that you are not someone who sits still very well. And I think you mentioned this a little bit in your LinkedIn profile, you like to keep moving. So one of the things that I noticed that you do, and I'd love if you share about it, is you do lectures on the history of innovation. Could you share a little bit about that? [00:20:24] Stuart Grant: Yeah. So. I I really, so I sort of got into reading about innovate. I love reading innovation books, right, nonfiction, innovation books, which I got in about 10 years ago. I read probably one of the first one was "The Idea Factory," which is about Bell Labs. And that was how Bell Labs has invented the telephone system and invented the transistor, won a load of Nobel Prizes. Shockley and Bardine were there. They just had this crazy Medici effect going on in Bell Labs. The Medici effect when you collect everybody together in a small area and they just start bouncing ideas and coming up with some hugely creative solutions. And that comes from Florence when DaVinci and Michelangelo and Raphael were all kicking about Florence and they were all paid for by the Medici family, so this why it's called the Medici. There's a book about it actually called "The Medici Effect." So I started reading all this and started just going backwards in history and getting to the industrial revolution and how the industrial revolution happened. And going further back to these group of men called the Lunar Men who were in Birmingham here in the UK who basically, it was James Watt, who invented the steam engine, Wedgewood, who was the pottery guy. It is Rasmus Darwin, who was Charles Darwin's great-grandfather. Yeah. All these people, they were called the Lunar Man 'cause they met every month in the full moon and discussed ideas and I think probably got drunk. [00:22:00] Lindsey Dinneen: I mean... [00:22:03] Stuart Grant: So yeah, I just love reading it and you know, I love, I'm now a little bit of a brag. As of last month, I'm a fellow of the Institute of Mechanical Engineers, and that is quite prestigious that was created by George Stevenson, and George Stevenson was the guy who created the steam train. [00:22:23] Lindsey Dinneen: Okay. [00:22:23] Stuart Grant: So we took Watts' idea of the steam engine, put it on wheels, figured out how to work. And I love, I just love steam trains and that's very dorky of me, I know. But I love, as a mechanical engineer, just seeing all the bits move and actually seeing them chug around all the noise and the steam. And here where I live in Yorkshire, in the UK, up the road in York is the National Railway Museum, which all the steam trains are at. Darlington is west. George Stevenson had his the original railway, the Darton Stock Railway. So George Stevenson created the Institute of Mechanical Engineers 'cause he was a mechanical engineer and his son created the rocket the first really fast once, Robert Stevenson. So learning all this and then figuring out how, then I went back-- I'm, so this is a long answer to your question-- then I went back went back and like understood why the industrial revolution happened and it was all about the banking system here, how people could get capital. And then the legal system grew up to protect that capital. And then agriculture improved in the UK so people weren't just stuck on farms, subsistence farming. There was enough food being produced to support the population so the population could go and work in factories and obviously James Watt creating the steam power created more power. So people in horses and everybody didn't have to work so hard. And then there was politics involved with the Hugonos, which were the Protestant, the French Protestants came over and they had all, they had the ability to make all these machine parts, 'cause that's our skill. Some of them came to the UK and the others went to Switzerland. And that's where the watch industry in Switzerland created. And then, you know, and then the scientific approach and the enlightenment came in the UK and it all just sort of bubbled up into the industrial revolution and then cascaded through the 19th century and the 20th century in. Here we are in the 21st century. So I just love knowing that whole pathway of somebody said "We need more legal," and then somebody said, "We need more banking" and as startups, right, investment is the king. So it all started 300 years ago with the UK banking system. [00:24:35] Lindsey Dinneen: Fascinating. Oh my goodness. That is so interesting. Yeah. Okay. One other interesting thing I caught from your LinkedIn profile is that you are a painter, but you are an exhibited painter, yes? [00:24:51] Stuart Grant: Yeah, I, well, I try. [00:24:54] Lindsey Dinneen: Okay. [00:24:54] Stuart Grant: So yeah. Obviously I did product design right? And I did product design because at school, I was good at art and I was good at maths and physics. So I was looking around going, "What discipline do those three things fit together?" And it looked like it was product design. I was like, "Okay, I'm half an engineer, half an artist, not good at either." So about 10 years ago I decided to pick up art again. It was, started to go to classes and doing landscapes and actually sadly the industrial decline of Britain's, so the old buildings of the industrial revolution and stuff like that. So I paint that stuff. [00:25:36] Lindsey Dinneen: Oh, that's so cool. [00:25:37] Stuart Grant: Put it into exhibitions and sometimes get rejected, sometimes get accepted, and try and sell a couple so I can at least call myself an artist. [00:25:45] Lindsey Dinneen: There you go. I love it. Yeah. Well, and that creativity and that artistry does, you know, impact your work in general, because I think sometimes having that outlet actually spurs some just creative solutions outside of the box that, you know, might have not come to you immediately if you were just like, you know, head down, really working hard on this project. And then if you could take a step back do you feel that it helps you in that way at all? [00:26:15] Stuart Grant: Yeah. Yeah, it definitely does. Not thinking about work is and just having it percolate in the background and not actually, 'cause it's a very slow deliberate process painting, right? So it does, you just lose hours and hours painting something, which is really nice. Obviously I've got a, I've got a 5-year-old at the moment running around, so I don't do that much painting. I usually just reserve it for when I go to my art class on Wednesday nights 'cause trying to focus is not a thing for a 5-year-old. [00:26:46] Lindsey Dinneen: Yeah, That's fair. Okay. Well, all right, so pivoting the conversation just for fun. Imagine that you were to be offered a million dollars to teach a master class on anything you want. It could be within your industry. It also could be your history of innovation, but what would you choose to teach? [00:27:08] Stuart Grant: So I thought about this when you gave that question because I was like, "Well, I've already talked about the history of innovation and that can pretty boring." So my other boring side, when you do a PhD, you always wish you did another subject. That's the thing is like, I wish I studied that instead. So my, as you go through the PhD, you learn other things and you're like, "Oh, that's really interesting." And you go down rabbit holes and you're like, "Oh, well stop. That's not my job. That's not what I'm trying to do here." One of the ones was how technology and society are interlinked. So technology drives society, and we've got lots of examples of that. Steam engines, trains, telephones, electricity, light bulb, broadband, and now AI. And so technology affects society. Then society drives technology. They're a virtuous circle. Some people say it not virtuous at all, but they, that's what happens. And understanding how those two things, society and culture and technology all interact is really interesting to me. And obviously not all technologies are adopted. Some are abandoned. Sometimes the better technology is abandoned for an inferior technology for lots and lots of reasons. There's examples. In the eighties, it was VHS and beta max, Blu-ray and HD DVDs. And what else? The keyboard, QWERTY keyboard is meant to be terrible. And that was designed 'cause of typewriters at the time. So the keys didn't smash together, but obviously that's not needed anymore. So those things interest me and I like to study that more, but I like to study it. Thinking about medtech and how our technology in medtech has affected society and using that lens 'cause we also always talk about clinical needs, right? What's your unmet clinical need? What are you trying to solve here? But there's also a social and cultural need that you are maybe not addressing directly, but you are addressing it. And how that drives medtech, and you know, it's we talk about like medtech equality and democratizing medtech and making it more accessible, but there's always the flip size of medtech inequalities. The big one probably at the moment is robotic surgery. Hugely expensive. Only available to very few. So how will that filter through society? How does that affect society? Will it just be for the rich developed countries to use robotic surgery? How will that affect it going forward the next 10, 20 years? Because it uses a capital equipment, right? They can't be diffused through society very easily. So that, that's one thing I would like to study and sort of talk about a little bit more, 'cause I think it's really interesting, especially now AI is being talked about and how digitizing healthcare is gonna happen over the next decade. Interesting if we're overclaiming that at the moment and a lot of startups are overclaiming, what they can really do and is it gonna, is there gonna be a backlash? Who knows? Let's see. In our, maybe in a decade, I'll present a course on it. [00:30:23] Lindsey Dinneen: There you go. Okay. And time will tell. Alright. I like it. Very cool. Okay. And how do you wish to be remembered after you leave this world? [00:30:34] Stuart Grant: Yeah. My PhD was like, I would probably like, I'd like to remember my PhD findings, but I'm like, no, who cares? [00:30:44] Lindsey Dinneen: Oh. [00:30:45] Stuart Grant: I, I've got, of course, my family, making an impact on my, what I've done here with my family, but, and I was really thinking about this question earlier. I was like, "Well, I hope this isn't the end. I hope I haven't peaked." [00:31:02] Lindsey Dinneen: Yes, that's fair, okay. [00:31:06] Stuart Grant: So maybe the next 20, 30 years, hopefully I'll be remembered for something, I hope. [00:31:12] Lindsey Dinneen: Okay. To be determined. I like that. I like that a lot all right. [00:31:18] Stuart Grant: It's a positive. [00:31:20] Lindsey Dinneen: Yeah. It's, and it's a forward way of thinking that, you know, you don't have to limit yourself to what you've already done or accomplished or seen. Who knows? The world is exciting. Yeah. I like it. Okay. [00:31:33] Stuart Grant: Well, yes, I'm yeah, definitely. [00:31:35] Lindsey Dinneen: Yeah, all. [00:31:36] Stuart Grant: One of the things we're doing-- I was looking at the Australian MedTech market and really just trying to figure out what's going on to see if there's anything I can do there. And talking to my wife, we decided, 'cause my daughter's not at school yet, we decided, "Let's go to Australia for an extended holiday." And it was gonna be like a month and we'll start working it all out, like we're just gonna go for three months, March, April and May this year, to sort of experience Australia, experience the MedTech market, go meet a lot of people, understand and just sort of grow and try to understand another way of people. I know Australia, they've got a similar culture to the UK and the US. But they do, they are far away. So they have a different take on things. And I wanna see what a difference is and see if I can get involved. So we're off to Australia on the MedTech market, so if anybody's listening, reach out to me on LinkedIn. It'll be we'll hopefully when I'm over there, we are in Brisbane. We can meet up. [00:32:32] Lindsey Dinneen: Excellent. Yeah, no, that's really exciting. And I actually have a few people I can connect you with as well, so, yeah. Okay. And then final question. What is one thing that makes you smile every time you see or think about it? [00:32:48] Stuart Grant: Oh. I think it's, it is back to my old answers, it's back to the steam trains. I just love watching the mechanism going around. My, me and my daughter who's exhibiting engineering characteristics, shall we say. Love, we love going to the railway museum and running around 'cause you can go and touch the trains, you can get on them, you can get your hands greasy if you want to, if you touch the wrong bit of it. She loves seeing them. And they're just, so when these engineers designed all these big bits of metal, they didn't have FEA or CAD or anything. They just sort of took a guess at the curves and how it should look. And some of these parts they designed are so beautiful when you start looking at them, it just makes me smile, like there was a person, a man, we'll have to say a man, right, 'cause it was 200 years ago... [00:33:44] Lindsey Dinneen: Right. [00:33:44] Stuart Grant: A engineer who decided he was gonna make it like that out of wood. And they were cast into iron and they just they were just sitting in their shop and just did what they thought was right. And most of the time it didn't break. [00:34:00] Lindsey Dinneen: Most of the time. There you go. Yeah. That's great. I love that. Well this has really been a fantastic conversation. I'm so grateful for you joining me today and sharing just some of your history and you know, what you're looking forward to next. I think it's, I think it's really incredible when you get to combine all the different things, like you said. You've got sort of that design and problem solving and you've got the engineering and you've got all these cool things that just make you an incredible help to the MedTech industry. And we're excited to be making a donation on your behalf, as a thank you for your time today, to Sleep in Heavenly Peace, which provides beds for children who don't have any in the United States. So thank you for choosing that charity to support. Thanks for joining and thanks for everything you're doing to change lives for a better world. [00:34:52] Stuart Grant: Yeah, thanks, Lindsey. It's been a real pleasure talking to you. [00:34:55] Lindsey Dinneen: Yeah, absolutely. Thank you again. [00:35:00] Dan Purvis: The Leading Difference is brought to you by Velentium Medical. Velentium Medical is a full service CDMO, serving medtech clients worldwide to securely design, manufacture, and test class two and class three medical devices. Velentium Medical's four units include research and development-- pairing electronic and mechanical design, embedded firmware, mobile app development, and cloud systems with the human factor studies and systems engineering necessary to streamline medical device regulatory approval; contract manufacturing-- building medical products at the prototype, clinical, and commercial levels in the US, as well as in low cost regions in 1345 certified and FDA registered Class VII clean rooms; cybersecurity-- generating the 12 cybersecurity design artifacts required for FDA submission; and automated test systems, assuring that every device produced is exactly the same as the device that was approved. Visit VelentiumMedical.com to explore how we can work together to change lives for a better world.

00:00:00 – Sleepless grind and brain-boosting hacks 00:04:53 – Alex Jones clips strategy and audience backlash 00:09:29 – Alex Jones bathroom supercut obsession 00:14:23 – Obama "aliens are real" headline vs clarification 00:19:22 – Havana syndrome microwaves and a scientist self-test 00:28:45 – Post-death consciousness and organ-harvest timing 00:37:13 – Daycare teacher dosing toddlers with laxatives 00:46:16 – Shipping container corpse clip and elite cover-up talk 00:50:44 – State Department scandal flashback and Epstein skepticism war 00:58:47 – Epstein emails: baby-buying claim and missing accountability 01:07:27 – Howard Lutnick's 9/11 timeline contradictions 01:12:05 – WTC7 theory and the "missing Epstein 9/11" thread 01:17:02 – Catherine Austin Fitts: Epstein as money-laundering infrastructure 01:22:00 – Zohran Mamdani rent-freeze pitch and tax reality 01:27:00 – "Free grocery store" stunt collapses under logistics 01:32:03 – NHS waitlist misery as the "free care" warning label 01:36:55 – Boneless wings lawsuit: nuggets vs "wings" semantics 01:41:55 – Meta-style AI doubles that post for you 01:46:54 – Audiophile blind tests dunk on magic cables 01:51:46 – "Space crime" bank-account drama from the ISS 01:56:19 – Wrap-up plugs and humanoid robot teaser Copyright Disclaimer Under Section 107 of the Copyright Act 1976, allowance is made for "fair use" for purposes such as criticism, comment, news reporting, teaching, scholarship, and research ▀▄▀▄▀ CONTACT LINKS ▀▄▀▄▀ ► Website: http://obdmpod.com ► Twitch: https://www.twitch.tv/obdmpod ► Full Videos at Odysee: https://odysee.com/@obdm:0 ► Twitter: https://twitter.com/obdmpod ► Instagram: obdmpod ► Email: ourbigdumbmouth at gmail ► RSS: http://ourbigdumbmouth.libsyn.com/rss ► iTunes: https://itunes.apple.com/us/podcast/our-big-dumb-mouth/id261189509?mt=2  

Lindsey Santoro shot to prominence at 2023's Edinburgh Fringe, winning Next Up's Biggest Award in Comedy with her show, Pink Tinge.Since then, Lindsey has created her hit BBC Radio 4 comedy series, The Lively Life of Lindsey Santoro, appeared on Live at the Apollo and supported Joe Lycett on tour! We discuss:using comedy as a tool for connectionbalancing a NHS day job with the crushing anxiety of early comedy gigsearning critical acclaim at Edinburgh, the financial surprises and attic life at the Pleasanceescaping imposter syndromethe importance of having a "base" outside of comedyand we find out if Lindsey Santoro is happy….Join the Insiders Club at Patreon.com/ComComPod where you can instantly WATCH the full episode and get access to 13 minutes of exclusive extras including:how Lindsey's BBC Radio 4 series came abouthow her agent kept her grounded through Edinburgh and balancing ambition with sanity

Hello you, welcome back to Hot History! I'm so excited for our 1st HOT TAKE episode and today, we're looking at WHY we're obsessed with the Nazis. So many of you sent in your take and I've loved deeping this big Q with you guys.Here are the 4 key reasons WHY based on what you sent in:1. Morbid Curiosity2. Nazi Showmanship3. Awful sense of awe4. Time & Scope5. Rise in right wing authoritarianismPLUS we look at when our obsession goes from curiosity (safe) to glorification (danger) and how to be aware of what motivates your consumption.Next week we're looking at the mysterious order of Parisian knights dating back to the crusades who guard Jesus' crown of thorns - or do they??If you're wanting more Hot History content you can follow along on ⁠⁠Instagram⁠⁠, ⁠⁠TikTok⁠⁠ and ⁠⁠YouTube⁠⁠ and of course, right here!Please take care while listening with the sensitive themes mentioned at the top and should you require assistance please use the below:In Australia, support is available 24/7 by calling or texting 0477 131 114 (lifeline) or 1300 22 4636 (Beyond Blue).In the USA,  support is available 24/7 by calling or texting 988 (988 Suicide & Crisis Lifeline) or texting HOME to 741741 for the Crisis Text Line.In the UK, support is available 24/7 by calling NHS 111  (NHS) or  116 123  (Samaritans)

Morse code transcription: vvv vvv I invested 12,000 in Brewdog I think Ive lost it all Vinicius Jr Eight years at Real Madrid, 20 cases of alleged racist abuse Mark Zuckerberg arrives to testify in social media addiction trial Billionaire Lex Wexner tells lawmakers he was naive and conned by Epstein Teenage girls lured into forced sex by gangs in London, BBC finds M4 Berkshire smart motorway crash how it happened NHS joint surgery disrupted amid bone cement supply problems Eight skiers found dead after California avalanche Norfolk farmer Tony Martin leaves 2.5m to loyal friend Do not give away Diego Garcia, says Trump

Host Sean Bean swaps the perfectly pruned for the beautifully wild, discovering how ponds, hedgerows and a little untidiness can transform your garden into a haven for wildlife.Along the way he's joined by broadcast legends and keen gardeners Zoë Ball and Jo While, ornithologist and environmentalist Dr Mya-Rose Craig, and NHS doctor and RSPB President Dr Amir Khan to explore why “messy” gardens are better for birds — and for our own heads too.We head to the Forest of Dean with a Forest Holidays ranger, hear from our resident beatboxer and nature sound artist Jason Singh on the great mimics of the sky, and dig into the science behind starling murmurations with Professor Anne Goodenough and artist Steve Geliot — exploring how these vast winter gatherings can lift us through life's hardest moments.Follow Get Birding on Instagram.This episode was produced by Hana Walker-Brown. The Executive Producer is Jane Gerber.This is a Get Birding Production. The podcast is made in collaboration with Forest Holidays, which encourages birdwatching as part of their guests' stays, with nature sensitive cabins available in 13 incredible locations across the UK. Use the code GETBIRDING26 when booking, for £40 off a 3-night break or £60 off a 4 or 7 night break. The code expires on 30 June 2026 and is for breaks bookable until 1 October 2026.To find out more, visit www.forestholidays.co.ukAn open access publication on starling murmurations (using citizen science) by Professor Anne Goodenough is available here https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0179277 Hosted on Acast. See acast.com/privacy for more information.

Morse code transcription: vvv vvv Norfolk farmer Tony Martin leaves 2.5m to loyal friend Do not give away Diego Garcia, says Trump Teenage girls lured into forced sex by gangs in London, BBC finds Vinicius Jr Eight years at Real Madrid, 20 cases of alleged racist abuse Eight skiers found dead after California avalanche I invested 12,000 in Brewdog I think Ive lost it all Billionaire Lex Wexner tells lawmakers he was naive and conned by Epstein M4 Berkshire smart motorway crash how it happened NHS joint surgery disrupted amid bone cement supply problems Mark Zuckerberg arrives to testify in social media addiction trial

Morse code transcription: vvv vvv Vinicius Jr Eight years at Real Madrid, 20 cases of alleged racist abuse Billionaire Lex Wexner tells lawmakers he was naive and conned by Epstein Mark Zuckerberg arrives to testify in social media addiction trial Teenage girls lured into forced sex by gangs in London, BBC finds M4 Berkshire smart motorway crash how it happened Norfolk farmer Tony Martin leaves 2.5m to loyal friend Do not give away Diego Garcia, says Trump NHS joint surgery disrupted amid bone cement supply problems Eight skiers found dead after California avalanche I invested 12,000 in Brewdog I think Ive lost it all

Today we're having an uncomfortable but very necessary conversation about antidepressants and the theory that these drugs work for those with depression by correcting imbalanced chemicals in their brain.Our guest to discuss this topic is Joanna Moncrieff, a Professor of Psychiatry at University College London, and works as a consultant psychiatrist in the NHS. She is author of numerous scientific papers including a major review that showed there was little evidence to support the idea that depression is caused by a serotonin abnormality. Her most recent book "Chemically Imbalanced: the making and unmaking of the serotonin myth” is what we're going to be discussing today.This was a complete eye opener for me. For years I believed in the pharmaceutical washed message that antidepressants worked because of a genuine brain chemical imbalance that we corrected with medications. This is not proven.Today we'll discuss over-use and misrepresentation of psychiatric drugs in the public sphere, the changing philosophy of mental health and how we got to a point where over 8 million people in the UK use antidepressants.We discuss what serotonin is, how we measure it in the body, why the imbalance theory is inconclusive, whether antidepressants have good evidence that they work and their many side effects.I want to make it clear that this episode is not meant to shame or belittle anyone on medications for mental health, but provide accurate information about how we can safely treat these problems and offer informed consent weighing up the pros and cons of medications like antidepressants. The use of these medications has well recognised withdrawal and dependency effects and should not be stopped without strict supervision of your medical practitioner. We've also linked to the Maudsley deprescribing guidelines here in the show notes for practitioners educating themselves on how to do this with their patients.Chemically Imbalanced BookWebsite: https://joannamoncrieff.com/

Elizabeth Cotton is Associate Professor of Responsible Business at the University of Leicester and the founder of Surviving Work, which carries out socially engaged research on mental health and work. She has worked with health teams and trade unions, practiced as a psychotherapist in the NHS, and now runs the Digital Therapy Project, a group of UK and US researchers studying the future of therapy from both sides of the relationship. In her new book, UberTherapy: The New Business of Mental Health, she explores the effects of reorganizing mental health care around the logic of the app store. Therapy is now something you can scroll through on your phone, match with in seconds, and rate like a ride share. Platforms promise frictionless access and personalized care. What is harder to see is how this new "mental health marketplace" is reshaping what therapy is, how it feels, and who it is really built to serve. UberTherapy is part political economy, part insider account of therapy work, part literary exploration of what it actually feels like to bring our most distressed selves to the mental health app ecosystem. In the second part of our conversation, Cotton traces how public austerity and platform capitalism have combined to turn mental health care into a set of digital products, governed by algorithms, data extraction, and dynamic pricing. In this world, qualified human therapists are slowly displaced by AI-driven "solutions," while those who remain are pushed into precarious, low-paid platform work. *** Thank you for being with us to listen to the podcast and read our articles this year. MIA is funded entirely by reader donations. If you value MIA, please help us continue to survive and grow. https://www.madinamerica.com/donate/ To find the Mad in America podcast on your preferred podcast player, click here: https://pod.link/1212789850 © Mad in America 2026. Produced by James Moore https://www.jmaudio.org

In this episode of The Fertility Podcast, I'm joined by Dr Carole Gilling-Smith, Medical Director of The Agora Clinic and Trustee of Fertility Action, to talk about family building within the LGBTQ+ community.If you are part of the LGBTQ+ community and thinking about becoming a parent, or you love someone who is, this episode is a practical starting point. We talk about treatment pathways, donor conception, fertility preservation, NHS inequality, and how to make sure you are supported properly by a clinic that understands your needs.This is about education, empowerment and knowing your options.What we cover in this episodeWhy fertility equality on the NHS is still not where it should beThe postcode lottery affecting IVF fundingWhy three full IVF cycles should be the national standardThe additional financial barriers faced by same sex couplesWhy six self funded IUIs before NHS eligibility is deeply problematicThe risks of sourcing donor sperm onlineChoosing between known donors and donor banksHow clinics should approach inclusive paperwork and languageWhy pronouns and preferred names matter in clinical settingsShared motherhood and reciprocal IVFFertility testing for both partners before deciding who carriesSupporting gay male couples through complex pathways involving egg donation and surrogacyWorking with the trans community around fertility preservationPreserving sperm or eggs before starting hormone treatmentThe emotional impact of genetic connection and non biological parentingWhy counselling is essential before treatment beginsSupporting patients who fear internal examinations or surgical environmentsCreating clinic spaces that feel safe, calm and inclusiveAbout Dr Carole Gilling-SmithDr Carole Gilling-Smith is the Medical Director of The Agora Clinic, one of the UK's leading fertility clinics for the LGBTQ+ community, based in Brighton and Hove.She is also a founding Trustee of Fertility Action, the UK charity campaigning for fertility equality and better access to treatment.Carole has been a long standing advocate for:Equal NHS funding for fertility treatmentInclusive fertility care for LGBTQ+ patientsFertility education in schools and universities

Tuesday, February 17, 2026 - Week 8   We are flat out, thank you to the team who work full-time on SYNGAP1: VM KAH LP PP & KF.   CLINICAL TRIAL DESIGN We are Angelman-like. (Rett also) https://aesnet.org/abstractslisting/differentiating-key-symptoms-of-angelman-syndrome-as-and-syngap1-via-caregiver-reported-and-us-claims-data-to-understand-differences-between-how-providers-and-caregivers-view-impacts-on-patient-care Dravet or Angelman?  Phase 1/2 is when we try it all.  EEGs and NHS help with this effort.   BIOSAMPLES & EEGs! Biorepository needs more samples.  Check out the list and map here https://combinedbrain.org/roadshow/ and contribute both blood & EEGs.  The data and research we do with these samples is invaluable.  Let us know if you are going, email our CSO@curesyngap1.org.   (Stay tuned for another exciting device study…)   NATURAL HISTORY STUDY Sign up for Citizen Health cureSYNGAP1.org/Citizen and ProMMiS cureSYNGAP1.org/ProMMiS NHS Survey in English: https://curesyngap1.org/SurveyProMMiS & Spanish: https://curesyngap1.org/encuestaProMMiS Latest Pod on NHS: https://youtu.be/7W38uWKBIAw?si=lCrffwMXidmYWz7t   FUNDRAISING - SPRINT4SYNGAP Sprint is April 25 - our calendar page - cureSYNGAP1.org/Sprint - has all the information in the following links: set up your team - cureSYNGAP1.org/Sprint26 resource guide for your event - cureSYNGAP1.org/S4SGuide webinar #99 to help get you started - cureSYNGAP1.org/S4S25   Also, May 28, San Francisco, CA: cureSYNGAP1.org/SF26 Scramble for Syngap - 5th annual on October 3 in S. Carolina cureSYNGAP1.org/Scramble26   PUBMED Pubmed 2026 is at 9! https://pubmed.ncbi.nlm.nih.gov/?term=syngap1&filter=years.2026-2026&sort=date (Remember we had 18 in all of ‘18) Cool connection to #PraderWilli Syndrome. https://www.linkedin.com/posts/graglia_syngap1-praderwilli-autism-share-7429579885985296385-zuIH   ETC - More warriors cureSYNGAP1.org/Warrior - Dr. Donlin-Asp Press Release cureSYNGAP1.org/PR42 see talk here https://www.youtube.com/watch?v=lR8qcZK-9ro - Bravo Sara Driscol and GeneDx https://www.linkedin.com/posts/genedx_beyondawareforrare-ugcPost-7427763511235248129-QPPL?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAAD8f4B7JC4TMss45Q8hrsq5kiceI0Z8HE   SOCIAL MATTERS 4,686 LinkedIn.  https://www.linkedin.com/company/curesyngap1 1,520 YouTube.  https://www.youtube.com/@CureSYNGAP1 11.2k Twitter https://twitter.com/cureSYNGAP1 45k Insta https://www.instagram.com/curesyngap1   $CAMP stock is at $3.85 on 17 Feb. ‘26 https://www.google.com/finance/beta/quote/CAMP:NASDAQ   Like and subscribe to this podcast wherever you listen.  https://curesyngap1.org/podcasts/syngap10/ Episode 199 of #Syngap10 #CureSYNGAP1 #Podcast

At last! It's here! Our long-awaited deep dive into the Levy review is here! In this episode, our hosts Ashleigh, Flint and Alyx take you through what the review got right, what it got wrong and where it didn't go far enough. This is a special episode and as such does not talk about the main news stories of the last few weeks. It's Levy all the way down this time. Normal service will be resumed as soon as we work out what that is.  The Beaches! The awesome Canadian band we mentioned. The Atomic Hound Dog! Ashleigh's old band. References: Dr Hilary Cass Chair Independent review of gender identity services for children and young people John Stewart National Director Streeting's response -Adult Services Review  Gender Identity Services for Adults (Non-Surgical Interventions) -NHS England NHS commissioning » Review of adult gender dysphoria services Review of the NHS adult gender dysphoria clinics in England: terms of reference and key lines of enquiry Arden GEM Review of NHS adult gender dysphoria clinics Engagement summary report of findings "The Levy Review" - Operational and delivery review of NHS adult gender dysphoria clinics in England NHS England's initial response to Dr Levy's Report Statement by Wes Streeting to HoC regarding the completed Adult Services Review Levy Review: A scathing audit of NHS Trans+ healthcare that isn't radical enough to fix the problems - Queer AF Some thoughts on the Levy Review - Dr Ruth Pearce The Levy review has been published | Good Law Project   

Dentistry is high on the public and political agenda. There have been dozens of headlines about access to NHS dentistry, with some people having to travel huge distances to find a dentist, or being put onto long waiting lists to get an NHS appointment. In this episode of Inside Health, James Gallagher is joined by chairman of the British Dental Association Eddie Crouch, the Oral Health Foundation's Dr Rachael England, and consultant oral surgeon Tom Thayer. Together, they drill into the issues surrounding NHS dentistry. Along the way, they discuss possible solutions, whether contract reforms will help, and the potential future of dentistry in the UK. Presenter: James Gallagher Producers: Alice Lipscombe-Southwell and Thomas Hunt Production coordinator: Stuart Laws Content editor: Ilan Goodman

Dan Richards investigates the multifaceted realm of night-time. Hear about when he survived a brush with death, a treacherous journey on a Scottish ferry, shadowing a search and rescue team, and the comfort and exquisite agony of new parenthood.The writer and broadcaster argues that night-time is universal in that everyone goes through it, but there are so many different experiences of the dark.He has met the many people who work, helping others and doing the invisible organising that keeps our communal world turning while others rest.Dan says the night is a place of encounters — both magical and disturbing.Further informationDan's book Overnight: Journeys, Conversations and Stories After Dark is published by Allen & Unwin.This episode was produced by Alice Moldovan. The Executive Producer is Nicola Harrison.This episode touches on sleep, covid, COVID, covid-19, hospital, emergency workers, NHS, ICU, frontline workers, search and rescue, dreams, outreach workers, homelessness, moominland, the shipping forecast, BBC, new fatherhood.To binge even more great episodes of the Conversations podcast with Richard Fidler and Sarah Kanowski go the ABC listen app (Australia) or wherever you get your podcasts. There you'll find hundreds of the best thought-provoking interviews with authors, writers, artists, politicians, psychologists, musicians, and celebrities.

What is it that really makes us healthy? Is it regular trips to the doctor, a swift diagnosis, and medicine when we need it? Or do we need a more holistic approach? Today's guest believes it is the latter.  Dr Gemma Newman has been a family doctor in the NHS for 20 years. She is regularly invited to speak and teach all over the world and is incredibly passionate about treating body, mind and spirit as one - and this forms the basis of her brand new book, Get Well Stay Well - The Six Healing Health Habits You Need To Know. Like me, Gemma increasingly found that her conventional medical training wasn't yielding positive results for many of her patients - so she decided to take a more open-minded approach, studying nutrition, psychotherapy and a range of other holistic methods and combined them with her conventional medical practice. And, very soon, she began to see radical transformations in the health of her patients. It's this holistic method that Gemma explains in our conversation today, using the acronym GLOVES - which points to six key areas of life we can address if we want to get well and stay well. They're ways of thinking, being and doing that should be front and centre in our lifestyles, and, of course, we discuss them all during our conversation together.  Crucially, Gemma, believes the first step in any effective, lasting behaviour change is finding self-compassion, and her approach will help you trust your inner wisdom, feel more in control, and stop outsourcing your wellbeing to the doctor's surgery. And in a world where ‘wellness' often comes with a hefty price tag, her suggestions are all free.  Gemma writes and speaks from the heart and I think you will really enjoy this conversation.   Support the podcast and enjoy Ad-Free episodes. Try FREE for 7 days on Apple Podcasts https://apple.co/feelbetterlivemore. For other podcast platforms go to https://fblm.supercast.com. Thanks to our sponsors: https://thewayapp.com/livemore https://ag1.com/livemore   Show notes https://drchatterjee.com/625   DISCLAIMER: The content in the podcast and on this webpage is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your doctor or qualified healthcare provider. Never disregard professional medical advice or delay in seeking it because of something you have heard on the podcast or on my website.

More than 141,000 children are in kinship care in England and Wales. According to new research from the charity Kinship, 40% of kinship carers are forced to claim benefits or increase their benefits when they step in to take on the care of a child from a family member. To explain why some kinship carers want the same parental rights as others in a parental role, like an adoptive parent, Clare McDonnell is joined by the CEO of Kinship, Lucy Peake and carer Nash, who took on the permanent care of her sister's children after her sister died.Broadcaster, model and activist Ashley James says she's always been underestimated and often written off as a ‘bimbo'. But now she's reclaiming the word as the title of her new book, which explores many of the judgmental labels used to describe women and their life choices. From 'bossy' to 'mumsy' to 'silly girl', Ashley joined Clare to unpack the impact such words can have on women and girls and why she hopes opening up about her own experiences will inspire others to stop shrinking and shake them off.Team GB snowboarder Mia Brookes gave an amazing performance coming fourth in the women's snowboard big air final at the Winter Olympics in Italy. The 19-year-old had been hoping to become Great Britain's first gold medallist on snow. She went for a backside 1620 trick - featuring four-and-a-half rotations - and landed before she over-rotated and her heel edge caught in the snow. Mia's mum, Vicky Brookes, joined presenter Nuala McGovern on the line from her campervan in Livigno close to the Olympic venue.Deborah Douglas has written a memoir about her experience as a victim turned campaigner in one of the biggest scandals in British medical history. Her story sits at the centre of the case of disgraced breast surgeon Ian Paterson, jailed in 2017 for performing harmful and unnecessary operations on women who believed they were being treated for cancer. An inquiry in 2020 found both NHS and private hospitals missed repeated chances to stop him. Deborah joined Clare to discuss The Cost of Trust.A new exhibition at the Charles Dickens museum celebrates the women who influenced the great Victorian novelist's female characters, social commentary and campaigning to improve the lives of vulnerable women. But how does this sit alongside the other, darker narrative, that Dickens himself was a misogynist who mistreated his own wife? To sort the fact from the fiction, the exhibition curator Kirsty Parsons & the historian Professor Jenny Hartley joined Nuala to discuss.Presenter: Clare McDonnell Producer: Annette Wells